Skip to content

Clinical Study on the Intervention Strategy Based on Swallowing Function Assessment for Preventing Aspiration Pneumonia in Elderly Patients with Neurodegenerative Diseases

Clinical Study on the Intervention Strategy Based on Swallowing Function Assessment for Preventing Aspiration Pneumonia in Elderly Patients with Neurodegenerative Diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112489
Enrollment
Unknown
Registered
2025-11-14
Start date
2025-12-15
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aspiration pneumonia

Interventions

Experimental group:Accurate assessment system for dysphagia and formulation of personalized physical therapy measures
Control group:routine assessment and diagnosis-treatment intervention

Sponsors

Aerospace Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >= 60 years old; 2.Diagnosed with senile neurodegenerative diseases in accordance with diagnostic criteria, such as Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, frontotemporal dementia, Huntington's disease, multiple sclerosis, etc.; 3.Having swallowing dysfunction of varying degrees or being at risk of abnormal swallowing function after preliminary screening; 4.The patient or their family members signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Complicated with life-threatening diseases such as severe cardiopulmonary failure and hepatic-renal insufficiency; 2.Recent history of oral or pharyngeal surgery, or acute infection in these areas; 3.Presence of mental disorders that prevent cooperation with researchers.

Design outcomes

Primary

MeasureTime frame
incidence rate of aspiration pneumonia;Death event;

Secondary

MeasureTime frame
Total hospitalization days;The duration of antibiotic treatment;The number of days admitted to the intensive care unit (ICU);Adverse reaction event;Situation of withdrawal from the study;

Countries

China

Contacts

Public ContactGuo Na

Aerospace Center Hospital

guona721gn@163.com+86 10 5997 1196

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026